• Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium Denmark Finland France Germany +7
  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Germany
  • Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Czechia Hungary Slovakia
  • Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Estonia France Germany Hungary +6
  • Study on Milrinone Infusion for Treating Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage

    Not recruiting

    3 1 1 1
    Investigated drugs:
    France
  • Study on Isatuximab, Pomalidomide, Dexamethasone, and Carfilzomib for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study of Pembrolizumab with Radiotherapy for Patients with Recurrent Prostate Cancer After Surgery

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Nivolumab and Tisagenlecleucel for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia After Treatment Loss

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Italy Spain
  • Study of Acalabrutinib for Patients with Waldenström Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Greece Italy

powered by